Stock ACL AUSTRALIAN CLINICAL LABS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Australian Clinical Labs Limited

Equities

ACL

AU0000148496

Healthcare Facilities & Services

Market Closed - Australian S.E.
Other stock markets
 02:11:03 2024-06-07 am EDT 		5-day change 1st Jan Change
2.31 AUD +0.87% Intraday chart for Australian Clinical Labs Limited +0.87% -20.07%
May. 28 Ord Minnett Starts Australian Clinical Labs at Buy, Price Target is AU$3.50 MT
May. 21 Australian Clinical Expects Fiscal 2024 Earnings to Fall at Lower End of Forecast MT

Valuation

Fiscal Period: June 2021 2022 2023 2024 2025 2026
Capitalization 1 686.2 921.8 694.2 463.2 - -
Enterprise Value (EV) 1 750.3 895.4 740 502.4 481 462.5
P/E ratio 8.57 x 5.19 x 19.3 x 16.6 x 12.3 x 10.8 x
Yield 4.19% 11.5% 4.07% 3.66% 4.8% 5.62%
Capitalization / Revenue 1.02 x 0.93 x 1 x 0.68 x 0.65 x 0.62 x
EV / Revenue 1.11 x 0.9 x 1.06 x 0.74 x 0.68 x 0.62 x
EV / EBITDA 3.25 x 2.4 x 4.01 x 2.72 x 2.44 x 2.22 x
EV / FCF - 3.41 x 5.41 x 14.2 x 10.4 x 9.57 x
FCF Yield - 29.4% 18.5% 7.03% 9.63% 10.4%
Price to Book - 3.99 x - 2.59 x 2.33 x 2.13 x
Nbr of stocks (in thousands) 201,834 200,834 201,812 200,503 - -
Reference price 2 3.400 4.590 3.440 2.310 2.310 2.310
Announcement Date 8/25/21 8/9/22 8/21/23 - - -
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2020 2021 2022 2023 2024 2025 2026
Net sales 1 519.5 674.4 995.6 697.1 683.3 711.3 746.5
EBITDA 1 - 230.7 372.7 184.7 184.9 197 208.4
EBIT 1 - 140 266.6 61.99 57.36 69.57 77.52
Operating Margin - 20.76% 26.78% 8.89% 8.39% 9.78% 10.39%
Earnings before Tax (EBT) 1 - - 254.9 48.31 40.38 53.27 62.08
Net income 1 41.3 60.37 178.2 35.9 28.46 37.77 44.04
Net margin 7.95% 8.95% 17.9% 5.15% 4.17% 5.31% 5.9%
EPS 2 - 0.3969 0.8846 0.1785 0.1393 0.1882 0.2140
Free Cash Flow 1 - - 262.8 136.7 35.33 46.33 48.33
FCF margin - - 26.4% 19.62% 5.17% 6.51% 6.47%
FCF Conversion (EBITDA) - - 70.52% 74.02% 19.11% 23.52% 23.19%
FCF Conversion (Net income) - - 147.46% 380.9% 124.14% 122.66% 109.75%
Dividend per Share 2 - 0.1425 0.5300 0.1400 0.0844 0.1108 0.1297
Announcement Date 5/13/21 8/25/21 8/9/22 8/21/23 - - -
1AUD in Million2AUD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: June 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2 2025 S1 2025 S2
Net sales 1 331.8 340.6 538 457.6 360.3 336.8 337.8 353.9 352.8 366.8
EBITDA 1 - - 239.3 133.4 99.82 84.93 87.1 100.2 97.8 102.4
EBIT 1 68.6 71.4 191 75.6 38.96 23.03 15.94 36.5 32.6 38.1
Operating Margin 20.68% 20.96% 35.5% 16.52% 10.81% 6.84% 4.72% 10.31% 9.24% 10.39%
Earnings before Tax (EBT) 1 - - 184.9 69.96 32.76 - - 28.25 24.4 30.1
Net income 1 - - 130.2 48.03 25.42 10.48 4.952 19.75 17 20.95
Net margin - - 24.2% 10.5% 7.06% 3.11% 1.47% 5.58% 4.82% 5.71%
EPS 2 - - 0.6454 0.2392 0.1265 0.0520 0.0246 0.0980 0.0850 0.1045
Dividend per Share 2 - - 0.1200 0.4100 0.0700 0.0700 0.0300 0.0430 0.0470 0.0575
Announcement Date 2/23/22 8/25/21 2/23/22 8/9/22 2/19/23 8/21/23 2/27/24 - - -
1AUD in Million2AUD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - 64.1 - 45.7 39.3 17.8 -
Net Cash position 1 - - 26.4 - - - 0.64
Leverage (Debt/EBITDA) - 0.2779 x - 0.2476 x 0.2123 x 0.0904 x -
Free Cash Flow 1 - - 263 137 35.3 46.3 48.3
ROE (net income / shareholders' equity) - 118% 113% 18.7% 18.1% 21.2% 21.5%
ROA (Net income/ Total Assets) - - 32.1% 6.54% 5.8% 6.65% 7.3%
Assets 1 - - 556.1 548.9 490.7 568 603.3
Book Value Per Share 2 - - 1.150 - 0.8900 0.9900 1.080
Cash Flow per Share 2 - 1.010 1.410 0.7100 0.7600 0.7900 0.5600
Capex 1 - - 21.3 6.93 8.2 9.43 10.3
Capex / Sales - - 2.13% 0.99% 1.2% 1.33% 1.37%
Announcement Date 5/13/21 8/25/21 8/9/22 8/21/23 - - -
1AUD in Million2AUD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Australian Clinical Labs Limited

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
2.31 AUD
Average target price
3.081 AUD
Spread / Average Target
+33.40%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
AUSTRALIAN CLINICAL LABS LIMITED Stock Australian Clinical Labs Limited
-20.07% 305M
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+26.08% 88.38B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-23.66% 77.56B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+8.73% 28.74B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
+7.45% 18.45B
LABCORP HOLDINGS INC. Stock Labcorp Holdings Inc.
-13.80% 16.57B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+2.60% 15.81B
NATERA, INC. Stock Natera, Inc.
+78.26% 13.65B
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+82.29% 13.06B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
+3.66% 12.61B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. ACL Stock
  4. Financials Australian Clinical Labs Limited